Please provide your email address to receive an email when new articles are posted on . Theragen has announced the issuance of a second U.S. patent for its ActaStim-S, a wearable and app-compatible ...
Bone Growth Stimulator Market is expected to reach $1.41 Billion by 2022, growing at a CAGR of 5.4% during the forecast period. The PRP segment is expected to grow at the highest CAGR primarily owing ...
Growing patient preference for noninvasive and minimally invasive surgical treatments. Procedural benefits offered by bone stimulation devices in bone fracture treatment. The report “Bone Growth ...
Please provide your email address to receive an email when new articles are posted on . Theragen Inc. has announced the issuance of a U.S. patent for the ActaStim-S, a spine fusion bone-growth ...
DUBLIN--(BUSINESS WIRE)--The "Bone Growth Products Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering. The Bone Growth Products Market was valued at USD ...
(MENAFN- EIN Presswire) EINPresswire/ -- The global bone growth stimulator market is expected to reach US$ 2.5 billion in 2026 and grow to US$ 3.7 billion by 2033, at a CAGR of 5.6% during the ...
Asia Pacific likely to emerge as the fastest-growing BGS Market. According to the new market research report “Bone Growth Stimulator Market by Product (Device (Implant, External), Bone Morphogenetic ...
JACKSONVILLE, Fla., Aug. 18, 2022 /PRNewswire/ -- Medical device company Theragen is pleased to announce the issuance of a U.S. Patent acknowledging its innovative approach to the development of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results